Skip to main content
. 2017 Nov 24;9(4):5492–5508. doi: 10.18632/oncotarget.23695

Table 2. The antagonists of β-catenin or other proteins in Wnt pathway and their possible mechanisms.

Name Possible mechanisms
PKF115-584183 Antagonist of the TCF/β-catenin complex Decreases both cytoplasmic and nuclear β-catenin expression
BC205947 Anthraquinone oxime analog Disrupts the binding of β-catenin to transducin β-like 1; Promotes β-catenin degradation
LF3180 Inhibits the β-catenin/TCF4 interaction Suppresses cell motility, cell-cycle progression, and the overexpression of Wnt target genes; Blocks the self-renewal capacity of cancer stem cells
ICG-001181 Inhibits β-catenin/CREBBP interaction Downregulates Wnt target genes
Salinomycin185 Small molecule inhibitor of LRP6 Downregulates Wnt target genes and cause cancer cell death
Calphostin C182 Antagonist of the TCF/β-catenin complex Degrades β-catenin via a proteasome-dependent
Xanthothricin182 Antagonist of the TCF/β-catenin complex Degrades β-catenin via a proteasome-dependent
FH535184 Suppresses β-catenin /TCF-mediated transcription